3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
37
Myelodysplastic Syndromes
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Leukemia
11
Hematologic Neoplasms
10
Lymphoma
9
Hodgkin Disease
9
Anemia, Refractory, with Excess of Blasts
9
Myeloproliferative Disorders
8
Multiple Myeloma
8
Lymphoma, Non-Hodgkin
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia, Biphenotypic, Acute
7
Graft vs Host Disease
7
Leukemia, Lymphocytic, Chronic, B-Cell
6
Primary Myelofibrosis
5
Neuroblastoma
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Myeloid
4
Congenital Abnormalities
4
Anemia, Aplastic
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Polycythemia Vera
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Panitumumab
1
IFL protocol
1
Gemcitabine
1
Cetuximab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis
×
Busulfan
×
1 year
×
Clear all
No trials found.